Abstract:BACKGROUND:Exposure to dietary aflatoxin B1 (AFB1) induces DNA damage and mutation in the TP53 gene at codon 249, known as the TP53 R249S mutation, and is a major risk factor for hepatocellular carcinoma (HCC). AFB1 and the hepatitis B virus (HBV) together exert synergistic effects that promote carcinogenesis and TP53 R249S mutation in HCC.METHODS:A genome-wide association study (GWAS) of whole genome exons was conducted using 485 HCC patients with chronic HBV infection. This was followed by an independent replication study conducted using 270 patients with chronic HBV infection. Immunohistochemistry was used to evaluate TP53 expression in all samples. This showed a correlation between codon 249 mutations and TP53 expression. Susceptibility variants for the TP53 R249S mutation in HCC were identified based on both the GWAS and replication study. The associations between identified variants and the expression levels of their located genes were analyzed in 20 paired independent samples.RESULTS:The likelihood of positive TP53 expression was found to be higher in HCC patients with the R249S mutation both in the GWAS (P<0.001) and the replication study (P=0.006). The combined analyses showed that the TP53 R249S mutation was significantly associated with three single nucleotide polymorphisms (SNPs): ADAMTS18 rs9930984 (adjusted P=4.84×10-6), WDR49 rs75218075 (adjusted P=7.36×10-5), and SLC8A3 rs8022091 (adjusted P=0.042). The TP53 R249S mutation was found to be highly associated with the TT genotypes of rs9930984 (additive model, P=0.01; dominant model, P=6.43×10-5) and rs75218075 (additive model, P=0.002; dominant model, P=2.16×10-4). Additionally, ADAMTS18 mRNA expression was significantly higher in HCC tissue compared with its expression in paired non-tumor tissue (P=0.041), and patients carrying the TT genotype at rs9930984 showed lower ADAMTS18 expression in non-tumor tissue compared with patients carrying the GT genotype (P=0.0028). WDR49 expression was markedly lower in HCC tissue compared with paired non-tumor tissue (P=0.0011).CONCLUSIONS:TP53 expression is significantly associated with the R249S mutation in HCC. Our collective results suggest that rs9930984, rs75218075, and rs8022091 are associated with R249S mutation susceptibility in HCC patients exposed to AFB1 and HBV infection.

Codon 249 Mutation in Exon 7 of P53 Gene in Plasma DNA: Maybe a New Early Diagnostic Marker of Hepatocellular Carcinoma in Qidong Risk Area, China.

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

Relationship Between P21,p53 Expression and Single Nucleotide Polymorphism with Hepatocellular Carcinoma

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Potential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China

Low Frequency of PIK3CA Gene Mutations in Hepatocellular Carcinoma in Chinese Population.

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.

Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.

Detection of P53 Gene Mutation in Plasma of Patients with Gastric Cancer

Genome-wide Association Study of the TP53 R249S Mutation in Hepatocellular Carcinoma with Aflatoxin B1 Exposure and Infection with Hepatitis B Virus

Establishment of a Prognostic Model for Predicting Short-Term Disease-Free Survival in Cases of Hepatitis B-related Hepatocellular Carcinoma with the TP53 249ser Mutation in Southern China

Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2′-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients

Hepatitis B 1762T/1764A Mutations, Hepatitis C Infection, and Codon 249 p53 Mutations in Hepatocellular Carcinomas from Thailand

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy

The P53 Mutation Spectrum in Hepatocellular Carcinoma from Guangxi, China : Role of Chronic Hepatitis B Virus Infection and Aflatoxin B1 Exposure.

Pre-S Deletion And Complex Mutations Of Hepatitis B Virus Related To Young Age Hepatocellular Carcinoma In Qidong, China

High Prevalence of Hepatitis B Virus Pre-S Mutation and Its Association with Hepatocellular Carcinoma in Qidong, China.

Association Of Hepatitis B Virus Pre-S Deletions With The Development Of Hepatocellular Carcinoma In Qidong, China

The Polymorphism of XRCC 3 Codon 241 and the Hotspot Mutation in the TP 53 Gene in Hepatocellular Carcinoma Induced by Aflatoxin B 1

Application of Plasma Circulating Cell-Free DNA Detection to the Molecular Diagnosis of Hepatocellular Carcinoma.

Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas